MS and COVID – MSBarts survey of people with MS
The way we conduct healthcare appointments has changed drastically in the past six months since Britain entered coronavirus lockdown. Remote appointments, shared-monitoring across professionals and those living with long-term conditions, and self-monitoring or treatment are all becoming the norm. However, it has been a fast transition for all, under forced circumstances. It is essential that […]
Survey results show early coronavirus impact on MS and Parkinson’s services
Neurology Academy have had a combined 133 UK-based responses to a short survey assessing the impact of coronavirus on multiple sclerosis (MS) and Parkinson’s services at the start of the pandemic. The survey found that over half of all those who responded had some staff redeployed from within their service to cover other essential health […]
The impact of COVID-19 on people living with MS: what the data says
The impact of the coronavirus pandemic has been extensive, pervasive, and for some, extreme in terms of both lifestyle and health. Routine health services have been reduced, curtailed, or halted entirely, individual lifestyle measures to manage stress and maintain movement have been affected, and ‘lockdown’ measures have placed additional duress on general mental health. For […]
COVID vaccines have implications for MS disease-modifying therapies
“Vaccine readiness” has become a hot topic in MS, which is often treated with immunosuppressive drugs. In a recent webinar (held on 21st May) hosted by MS Academy, Professor Gavin Giovannoni and Professor David Baker discussed the likelihood of people living with MS being able to respond to a COVID-19 vaccine. At that time, just […]
Neurology Academy during the COVID-19 pandemic
On 23rd March 2020, our society was changed overnight. The announcement of a UK-wide lockdown due to the coronavirus pandemic meant a drastic change to everyone’s lives, and to our health service. Health professionals were redeployed to frontline services, regular clinics for diagnosis and review were suspended and frantic attempts to use telehealth and other […]
Webinar: Siponimod – how do we give patients with secondary progressive MS hope?
Please note that all session and slide content are the views of the Speakers, not the MS Academy. The content of the recording is the speaker’s personal opinion at the time of recording. Due to the everchanging situation, advice given at the time of recording is subject to change. Are the ‘Forgotten Many’ forgotten again? […]
Essential neurorehabilitation in the aftermath of COVID-19
The impact of coronavirus on our health service has been highly documented, but with the first wave passed, the burden has not lifted, but altered, in the form of rehabilitation. Earlier this week, we highlighted an article in Reuters which has since been echoed in multiple publications – the long-term implications of COVID-19 on a […]
Webinar: Neuro rehabilitation – now and the future
Please note that all session and slide content are the views of the Speakers, not the MS Academy. The content of the recording is the speaker’s personal opinion at the time of recording. Due to the everchanging situation, advice given at the time of recording is subject to change. This session will provide some insight […]
Webinar: MS – the future
Please note that all session and slide content are the views of the Speakers, not the MS Academy. The content of the recording is the speaker’s personal opinion at the time of recording. Due to the everchanging situation, advice given at the time of recording is subject to change. CPD acceditation This webinar has been approved […]
The long term implications of COVID-19 are becoming apparent
We have become increasingly aware, over the past few months, that the symptoms of COVID-19 are wider ranging than initially thought. A recent article in Reuters has highlighted the full extent of this, and called into question whether we are prepared, as a society, for the rehabilitative process that will be needed by many who […]